全球生物影像市場：按診斷影像方法、最終用戶和地區分類

全球生物成像市場預計到 2026 年將達到 93.4 億美元，到 2033 年將達到 259.1 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 15.7%。

生物成像是一項強大且不可或缺的技術，廣泛應用於生物科學和醫學領域。它涵蓋了從分子層面到器官層面的生物系統結構和功能資訊的獲取、處理和可視化等一系列技術。生物影像的主要目標是深入了解複雜的生物過程，促進精準的醫學診斷，並指南介入和治療。透過利用X光、磁振造影（MRI）、正子斷層掃描（PET）、超音波和光學顯微鏡等多種技術，生物成像提供了一種非侵入性觀察生物體運作的手段。這使得研究人員和臨床醫生能夠即時觀察細胞和組織內的複雜相互作用，從而奠定了現代診斷和疾病機制研究的基礎。近年來，生物成像技術的進步已將其應用範圍擴展到奈米尺度，實現了對細胞和分子水平事件的即時追蹤。超高解析度顯微鏡、光聲成像和生物發光等技術以前所未有的細節揭示了生物體的運作機制，加深了我們對健康和疾病相關生物路徑的理解。生物成像是一個本質上跨學科的領域，涵蓋物理學、工程學、生物學、化學、電腦科學和醫學。它需要整合高解析度成像設備、先進的影像分析軟體以及對潛在生物過程的深刻理解。在應用方面，生物成像在研究實驗室和臨床環境中都不可或缺。它有助於疾病的早期檢測，提高手術精度，並促進標靶藥物療法的研發。成像技術不斷發展，有望透過實現個人化治療（充分考慮每位患者獨特的生物學特徵）來革新個人化醫療。因此，生物成像處於科學進步的前沿，彌合了基礎研究和臨床應用之間的鴻溝，並引領著醫學創新的未來。

市場動態：

受人口老化、慢性病和文明病發病率上升、診斷成像技術進步以及醫療保健成本不斷上漲等多種因素的推動，全球生物成像市場預計在預測期內將保持強勁成長。然而，生物影像系統、診斷程序和放射性示蹤劑的高成本仍然是重大挑戰。此外，各種關於輻射暴露的指南和法規也阻礙了市場成長。儘管如此，新興市場尚未開發的機會預計將在不久的將來為市場相關人員創造新的商機。

本研究的主要特點：

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數介紹了全球生物成像市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 全球生物成像市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用全球生物成像市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
    • 生物成像技術的技術進步
  • 抑制因子
    • 需要大量資金投入。
  • 機會
    • 混合成像系統
• 主要亮點
• 監管趨勢
• 近期趨勢
• PEST分析
• 波特的分析
• 併購和合作

第4章 全球生物影像市場：依影像方式分類，2021-2033年

• 磁振造影（MRI）
• 電腦斷層掃描（CT）
• 正子斷層掃描（PET）
• 超音波
• X光
• 其他

第5章 全球生物影像市場：依最終用戶分類，2021-2033年

• 醫院和診斷中心
• 學術研究機構
• 製藥和生物技術公司
• 其他

第6章 全球生物影像市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 中非
  • 北非

第7章 競爭情勢

• 公司簡介
  • Bracco Imaging SPA
  • Bayer HealthCare Pharmaceuticals
  • Esaote SpA
  • Digirad Corporation
  • FONAR Corporation
  • GE Healthcare
  • Hologic Inc
  • Hitachi Medical Corporation
  • Lantheus Medical Imaging, Inc.
  • Covidien Pharmaceuticals
  • Mindray Medical International Limited.
  • Gamma Medica Inc
  • Samsung Medison Co., Ltd.
  • Philips Healthcare
• 分析師意見

第8章

• 參考
• 調查方法
• 關於本公司

Global Bio-imaging Market is estimated to be valued at USD 9.34 Bn in 2026 and is expected to reach USD 25.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.7% from 2026 to 2033.

Bio-imaging is a powerful and essential technique that is widely used in the realm of biological and medical sciences. It refers to the ensemble of technologies that capture, process, and visualize structural and functional information of biological systems, ranging from the molecular to the organ level. The primary goal of bio-imaging is to gain a deeper understanding of complex biological processes, facilitate accurate medical diagnoses, and guide interventions and therapies. By leveraging diverse technologies such as X-ray, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, and optical microscopy, bio-imaging provides a non-invasive window into the inner workings of living organisms. It allows researchers and clinicians to observe the intricate interactions within cells and tissues in real-time, thereby making it a cornerstone in modern diagnostics and research on disease mechanisms. Recent advancements have expanded the frontiers of bio-imaging to nano-scale dimensions and have enabled real-time tracking of cellular and molecular events. Techniques such as super-resolution microscopy, photo acoustic imaging, and bioluminescence have brought unprecedented details to light, deepening our comprehension of biological pathways involved in health and disease. Fundamentally interdisciplinary, bio-imaging encompasses physics, engineering, biology, chemistry, computer science, and medicine. It demands the integration of high-resolution imaging instruments, sophisticated software for image analysis, and a profound knowledge of the underlying biological processes. In terms of its applications, bio-imaging is indispensable in research laboratories and healthcare settings. It aids in the early detection of diseases, enhances the precision of surgical procedures, and contributes to the development of targeted drug therapies. As bio-imaging technology continues to evolve, it promises to revolutionize personalized medicine by enabling a tailored approach to treatment that considers the unique biological makeup of each patient. Thus, bio-imaging stands at the forefront of scientific progress, bridging the gap between basic research and clinical application, and driving the future of healthcare innovations.

Market Dynamics:

Global bio-imaging market is expected to witness robust growth over the forecast period, due to several factors such as rising geriatric population, increasing incidence of chronic and lifestyle diseases, technological advancements in imaging modalities, and growing healthcare expenditure. However, high costs that are associated with bio-imaging systems, procedures, and radiotracers remain a major challenge. Several guidelines and regulations pertaining to radiation exposure also act as a restraint for the market. Nevertheless, untapped opportunities in emerging economies are likely to create new avenues for market players in the near future.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bio-imaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc, Samsung Medison Co., Ltd., and Philips Healthcare.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bio-imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analysing the global bio-imaging market

Detailed Segmentation:

• Global Bio-imaging Market Segmentation, By Imaging Modality (Revenue, USD Bn, 2021 - 2033)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Position Emission Tomography (PET)
• Ultrasound
• X-ray
• Others
• Global Bio-imaging Market Segmentation, By End User (Revenue, USD Bn, 2021 - 2033)
• Hospitals & diagnostic centers
• Academic & research institutes
• Pharmaceutical & biotech companies
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top Companies in Global Bio-imaging Market:
• Bracco Imaging S.P.A
• Bayer HealthCare Pharmaceuticals
• Esaote S.p.A
• Digirad Corporation
• FONAR Corporation
• GE Healthcare
• Hologic Inc
• Hitachi Medical Corporation
• Lantheus Medical Imaging, Inc.
• Covidien Pharmaceuticals
• Mindray Medical International Limited.
• Gamma Medica Inc
• Samsung Medison Co., Ltd.
• Philips Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Bio-imaging, By Imaging Modality
  • Market Bio-imaging, By End User
  • Market Bio-imaging, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
    • Technological advancements in bio-imaging modalities
  • Restraints
    • High capital investment requirements
  • Opportunities
    • Hybrid imaging systems
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Bio-imaging Market, By Imaging Modality, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Position Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Ultrasound
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• X-ray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Bio-imaging Market, By End User, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals & diagnostic centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Academic & research institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Pharmaceutical & biotech companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Bio-imaging Market, By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022 -2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

• Company Profile
  • Bracco Imaging S.P.A
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer HealthCare Pharmaceuticals
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Esaote S.p.A
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Digirad Corporation
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • FONAR Corporation
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic Inc
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hitachi Medical Corporation
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lantheus Medical Imaging, Inc.
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Covidien Pharmaceuticals
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mindray Medical International Limited.
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Gamma Medica Inc
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Samsung Medison Co., Ltd.
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Imaging Modality Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About us